Table S1 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases

Table S1 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases

<p>Read sequencing depth by sample</p>

保存先:

書誌詳細
第一著者:	N. Ari Wijetunga (15056183) (author)
その他の著者:	Alexander G. Goglia (15056186) (author), Nils Weinhold (15056189) (author), Michael F. Berger (15048171) (author), Michael Cislo (15056192) (author), Daniel S. Higginson (14949837) (author), Kiana Chabot (15056195) (author), Ahmed M. Osman (15056198) (author), Lauren Schaff (15056201) (author), Elena Pentsova (15056204) (author), Alexandra M. Miller (15056207) (author), Simon N. Powell (15056210) (author), Adrienne Boire (14944705) (author), Jonathan T. Yang (15056213) (author)
出版事項:	2025
主題:	Cancer Therapeutic Research and Development Methods and Technology CNS Cancers Gene Technologies High-throughput sequencing Liquid Biopsy Radiation Oncology Molecular targets of radiation response Translational Research
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Table S2 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases
著者:: N. Ari Wijetunga (15056183)
出版事項: (2025)

Table S3 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases
著者:: N. Ari Wijetunga (15056183)
出版事項: (2025)

Table S4 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases
著者:: N. Ari Wijetunga (15056183)
出版事項: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
著者:: Francesca Orzan (15055579)
出版事項: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
著者:: Francesca Orzan (15055579)
出版事項: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
著者:: Francesca Orzan (15055579)
出版事項: (2025)

Supplementary Figure S1 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
著者:: Rumani Singh (17141575)
出版事項: (2025)

Supplementary Figure S2 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
著者:: Rumani Singh (17141575)
出版事項: (2025)

Supplementary Figure S3 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
著者:: Rumani Singh (17141575)
出版事項: (2025)

Supplementary Figure S4 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
著者:: Rumani Singh (17141575)
出版事項: (2025)

Supplementary Figure S5 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
著者:: Rumani Singh (17141575)
出版事項: (2025)

Supplementary Figure S6 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
著者:: Rumani Singh (17141575)
出版事項: (2025)

Supplementary Table S1 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
著者:: Mengjie Zhao (14845174)
出版事項: (2025)

Supplementary Table S2 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
著者:: Mengjie Zhao (14845174)
出版事項: (2025)

Supplementary Table S4 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
著者:: Mengjie Zhao (14845174)
出版事項: (2025)

Supplementary Table S5 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
著者:: Mengjie Zhao (14845174)
出版事項: (2025)

Supplementary Table S8 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
著者:: Mengjie Zhao (14845174)
出版事項: (2025)

Supplemental Figure 1 from Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast
著者:: Amy C. Degnim (15106462)
出版事項: (2025)

Supplemental Figure 2 from Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast
著者:: Amy C. Degnim (15106462)
出版事項: (2025)

Supplemental Figure 3 from Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast
著者:: Amy C. Degnim (15106462)
出版事項: (2025)

Supplementary Appendix S1 from DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
著者:: Bouchra Tawk (15389486)
出版事項: (2025)

Figure 1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
著者:: Gonzalo Rodriguez-Berriguete (15056057)
出版事項: (2025)

Figure 2 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
著者:: Gonzalo Rodriguez-Berriguete (15056057)
出版事項: (2025)

Figure 3 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
著者:: Gonzalo Rodriguez-Berriguete (15056057)
出版事項: (2025)

Figure 4 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
著者:: Gonzalo Rodriguez-Berriguete (15056057)
出版事項: (2025)

Figure 5 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
著者:: Gonzalo Rodriguez-Berriguete (15056057)
出版事項: (2025)

Supplementary Table S1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
著者:: Gonzalo Rodriguez-Berriguete (15056057)
出版事項: (2025)

Immunohistochemical staining for PHLDA3, APOE, and CPE in irradiated brain tissues.
著者:: Jing Liu (38537)
出版事項: (2025)

Supplementary Table 1 from Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy
著者:: Naoshad Muhammad (14960127)
出版事項: (2025)

Supplementary Table 2 from Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy
著者:: Naoshad Muhammad (14960127)
出版事項: (2025)

Global Wildfire Brown Carbon Simulation Results: Supporting Data for "Strong Shortwave Absorption by Wildfire Brown Carbon from Global Observations and Modeling"
著者:: Lulu Xu (21634004)
出版事項: (2025)

2024 Meteorological Data, Upper Chesapeake Bay, MarineGEO, Smithsonian Environmental Research Center
著者:: Sam Benson (17684957)
出版事項: (2025)

Supplementary Figure 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
著者:: Michelle L. Mierzwa (14963463)
出版事項: (2025)

Supplementary Tables S1-S11 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
著者:: Sami Belhadj (15052341)
出版事項: (2025)

Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients
著者:: Cloud P. Paweletz (14960112)
出版事項: (2025)

Supplementary Data 1 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
著者:: Whitney L. Hensing (16461978)
出版事項: (2025)

Supplementary Table S1 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Supplementary Table S2 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Supplementary Table S3 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Supplementary Table S4 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
著者:: Stephanie Lheureux (16797697)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_npuipa5ci7k8b8e42tvfro0qh0